Clinical Trial Update: Unimolecular Pentavalent (Globo-H-GM2-sTn-TF-Tn) Immunization of Patients With Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission [Phase 1]

View source ↗

Summary

A Phase 1 study of a unimolecular pentavalent immunization (Globo-H-GM2-sTn-TF-Tn) in patients with epithelial ovarian cancer, fallopian tube cancer, or periton…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Unimolecular Pentavalent Immunization (Globo-H-GM2-sTn-TF-Tn)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Fallopian Tubes, Ovarian Cancer | Phase 1 | Status: COMPLETED